AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17347180 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 80
Study 15264735 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60
Study 15264735 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube
Number of subjects: 60
Study 11555849 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma IGF‐I measurement
Number of subjects: 35
Study 11555849 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IGFBP‐3 measurement
Number of subjects: 35
Study 11555849 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum leptin measurement (women)
Number of subjects: 35
Study 11555849 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum leptin measurement (men)
Number of subjects: 35
Study 11555849 — intervention group
Group type: COMPARATOR
Intervention: Serum IGFBP‐3 and serum leptin compared to plasma IGF‐I
Number of subjects: 35
Study 9670267 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated hyperthermic arterial liver perfusion
Number of subjects: 12
Study 7923312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen lysine 200 mg (IBL 200)
Number of subjects: 183
Study 7923312 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid 500 mg (ASA 500)
Number of subjects: 183
Study 7923312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 2971512 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 percent clindamycin phosphate gel
Number of subjects: 135
Study 2971512 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 percent clindamycin phosphate solution
Number of subjects: 135
Study 2971512 — intervention group
Group type: COMPARATOR
Intervention: Placebo (gel vehicle)
Number of subjects: 135
Study 31391223 — intervention group
Group type: EXPERIMENTAL
Intervention: ralinepag
Number of subjects: 61
Study 31391223 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study 27708251 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 16
Study 27708251 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 16
Study 25438838 — intervention group
Group type: EXPERIMENTAL
Intervention: MRgHIFU (transcranial magnetic resonance imaging-guided high-intensity focused ultrasound)
Number of subjects: 0
Study 25438838 — intervention group
Group type: EXPERIMENTAL
Intervention: MRgHIFU
Number of subjects: 0
Study 23294132 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA)
Number of subjects: 60
Study 23294132 — intervention group
Group type: COMPARATOR
Intervention: Continuous Infusion
Number of subjects: 60
Study 21536983 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg daily)
Number of subjects: 80
Study 21536983 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol succinate (50 to 100 mg daily)
Number of subjects: 80
Study 19561368 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual-reality-based exercise bike therapy
Number of subjects: 30
Study 19561368 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation therapy without virtual-reality equipment
Number of subjects: 30
Study 16432820 — intervention group
Group type: EXPERIMENTAL
Intervention: Transilluminated powered phlebectomy (TIPP)
Number of subjects: 62
Study 16432820 — intervention group
Group type: COMPARATOR
Intervention: Multiple stab incision phlebectomy (MSIP)
Number of subjects: 62
Study 15471147 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 0
Study 15471147 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 0
Study 11590875 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.2 g n‐3 PUFA daily for 12 weeks
Number of subjects: 55
Study 11590875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 9125088 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical/Biological Combat Suit (CBCS)
Number of subjects: 9
Study 9125088 — intervention group
Group type: COMPARATOR
Intervention: Normal combat uniform (DPCU)
Number of subjects: 9
Study 9125088 — intervention group
Group type: COMPARATOR
Intervention: Combat uniform (CS)
Number of subjects: 9
Study 7932174 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-desacetylvecuronium
Number of subjects: 12
Study 7932174 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 12
Study 2979237 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral micronized testosterone (200 mg t.d.s.)
Number of subjects: 25
Study 2979237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 29878856 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% Hypertonic Saline (HS)
Number of subjects: 28
Study 29878856 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% Hyaluronic Acid + 7% Hypertonic Saline (HA+HS)
Number of subjects: 28
Study 29878856 — intervention group
Group type: COMPARATOR
Intervention: 0.9% Isotonic Saline (IS)
Number of subjects: 28
Study 29878856 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Clearance Technique (ACT)
Number of subjects: 28
Study 29878856 — intervention group
Group type: EXPERIMENTAL
Intervention: Leicester Cough Questionnaire (LCQ) and lung function measurements
Number of subjects: 28
Study 29878856 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs) monitoring
Number of subjects: 28
Study 27049056 — intervention group
Group type: EXPERIMENTAL
Intervention: Test spironolactone tablet formulation (100 mg) under fasting condition
Number of subjects: 40
Study 27049056 — intervention group
Group type: EXPERIMENTAL
Intervention: Test spironolactone tablet formulation (100 mg) under fed condition
Number of subjects: 40
Study 27049056 — intervention group
Group type: COMPARATOR
Intervention: Reference spironolactone tablet formulation (100 mg) under fasting condition
Number of subjects: 40
Study 27049056 — intervention group
Group type: COMPARATOR
Intervention: Reference spironolactone tablet formulation (100 mg) under fed condition
Number of subjects: 40
Study 25653225 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroneal nerve functional electrical stimulation (FES)
Number of subjects: 495
Study 25653225 — intervention group
Group type: COMPARATOR
Intervention: Ankle foot orthosis (AFO)
Number of subjects: 495
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Various drugs (90 drugs assessed)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (antiarrhythmic)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (antihistaminic)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine (antiarrhythmic)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimipramine (tricyclic antidepressant)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (tricyclic antidepressant)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide (antiarrhythmic)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine (antipsychotic)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol (beta blocker)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole (antifungal)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (decongestant/anorectic)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine (appetite suppressant)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (antihypotensive)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (cardiac glycoside/antiarrhythmic)
Number of subjects: 59467
Study 23857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide (antiarrhythmic)
Number of subjects: 59467
Study 21135270 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) delivered to 30 Gy in 15 fractions
Number of subjects: 340
Study 21135270 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 340
Study 18356180 — intervention group
Group type: EXPERIMENTAL
Intervention: Shockwave therapy
Number of subjects: 14
Study 16735587 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular retraction position
Number of subjects: 30
Study 16735587 — intervention group
Group type: COMPARATOR
Intervention: Empty-can arm position
Number of subjects: 30
Study 14551341 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 5187
Study 14551341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5187
Study 11373850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic screening in the United Kingdom
Number of subjects: 65390
Study 11373850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic screening in Western Australia
Number of subjects: 65390
Study 11373850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic screening in Denmark
Number of subjects: 65390
Study 9504729 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril 20 mg once daily
Number of subjects: 96
Study 9504729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 9504729 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 96
Study 8040678 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin and dexrazoxane (600/120 mg/m2, 900/120 mg/m2, 900/135 mg/m2, 900/150 mg/m2, 1,200/135 mg/m2)
Number of subjects: 38
Study 8040678 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin alone
Number of subjects: 38
Study 8040678 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin and dexrazoxane
Number of subjects: 38
Study 2493868 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling by health visitors (8 weekly visits)
Number of subjects: 60
Study 2493868 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counselling)
Number of subjects: 60
Study 9890791 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipropylacetate (Depakine, 20 mg/kg)
Number of subjects: 47
Study 9890791 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbital (5 mg/kg)
Number of subjects: 47
Study 9890791 — intervention group
Group type: COMPARATOR
Intervention: Primidone (25 mg/kg)
Number of subjects: 47
Study 9890791 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 47
Study 31088417 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (41 clubs)
Number of subjects: 79
Study 31088417 — intervention group
Group type: COMPARATOR
Intervention: Control group (38 clubs)
Number of subjects: 79
Study 28193663 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-targeted education about the etiology of URTIs, the role of antibiotics, and consequences of inappropriate antibiotic use.
Number of subjects: 914
Study 28193663 — intervention group
Group type: COMPARATOR
Intervention: Control arm education on influenza vaccinations.
Number of subjects: 914
Study 26444473 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Diabetes Risk Score (DRS) provided at baseline, 12, and 24 weeks
Number of subjects: 192
Study 26444473 — intervention group
Group type: COMPARATOR
Intervention: Control group received DRS at 12 and 24 weeks
Number of subjects: 192
Study 23504552 — intervention group
Group type: EXPERIMENTAL
Intervention: Locomotor training program (LTP) - 36 therapist-provided sessions of walking training on a treadmill using body-weight support and practice overground at clinics
Number of subjects: 408
Study 23504552 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise program (HEP) - 36 therapist-provided sessions of impairment-based strength and balance exercise at home
Number of subjects: 408
Study 23504552 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 408
Study 21554109 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 75
Study 21554109 — intervention group
Group type: COMPARATOR
Intervention: Educational film (control) group
Number of subjects: 75
Study 21554109 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study 19055279 — intervention group
Group type: EXPERIMENTAL
Intervention: Mimetic muscle acupuncture group (n = 79)
Number of subjects: 134
Study 19055279 — intervention group
Group type: COMPARATOR
Intervention: Routine acupoint group (n = 55)
Number of subjects: 134
Study 16685332 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual review using simple search and replace algorithms and visual scanning
Number of subjects: 262
Study 16685332 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated review for easy PHI
Number of subjects: 262
Study 16685332 — intervention group
Group type: COMPARATOR
Intervention: Comparison between manual and automated techniques
Number of subjects: 262
Study 12665164 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental diet containing eicosapentaenoic acid, gamma-linolenic acid, and elevated antioxidants
Number of subjects: 98
Study 12665164 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 98
Study 11052845 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser guidewire
Number of subjects: 303
Study 11052845 — intervention group
Group type: COMPARATOR
Intervention: Mechanical guidewire
Number of subjects: 303
Study 9175371 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antibiotic combined with piroxicam eye drops
Number of subjects: 75
Study 9175371 — intervention group
Group type: COMPARATOR
Intervention: Topical antibiotic eye drops alone
Number of subjects: 75
Study 1283661 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA) 5 g administered after induction of anesthesia and 2 g/h during surgery
Number of subjects: 60
Study 1283661 — intervention group
Group type: COMPARATOR
Intervention: Aprotinin (APROT) 2.10(6) UIK administered after induction of anesthesia and 5.10(5) UIK/h during surgery
Number of subjects: 60
Study 30700474 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative CapeOX chemotherapy (up to four cycles every 3 weeks) plus radical surgery plus up to four cycles of postoperative chemotherapy
Number of subjects: 1370
Study 30700474 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chemotherapy (up to eight cycles after radical surgery)
Number of subjects: 1370
Study 29301586 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention (booklet and video, home visit at 34-36 weeks, telephone call 4 weeks after birth)
Number of subjects: 128
Study 29301586 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention
Number of subjects: 128
Study 29301586 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 128
Study 27062400 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Based Treatment (FBT)
Number of subjects: 158
Study 27062400 — intervention group
Group type: COMPARATOR
Intervention: Systemic Family Therapy (SyFT)
Number of subjects: 158
Study 27062400 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 158
Study 24641767 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored interventions to help implement NICE guidelines for overweight and obesity
Number of subjects: 0
Study 24641767 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 22955513 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate fat ingestion (MF) - 0.7 g of fat/kg body weight
Number of subjects: 20
Study 22955513 — intervention group
Group type: COMPARATOR
Intervention: Low fat ingestion (LF) - 0.4 g of fat/kg body weight
Number of subjects: 20
Study 22955513 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate fat ingestion (MF)
Number of subjects: 20
Study 22955513 — intervention group
Group type: COMPARATOR
Intervention: Low fat ingestion (LF)
Number of subjects: 20
Study 19596616 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydro-jet
Number of subjects: 79
Study 19596616 — intervention group
Group type: COMPARATOR
Intervention: Needle injection
Number of subjects: 79
Study 19596616 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study 17914085 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous granisetron (3 mg)
Number of subjects: 31
Study 17914085 — intervention group
Group type: COMPARATOR
Intervention: Intravenous granisetron (3 mg)
Number of subjects: 31
Study 16208801 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating/pulsating power toothbrush (Oral‐B ProfessionalCare 7000; PC 7000)
Number of subjects: 35
Study 16208801 — intervention group
Group type: COMPARATOR
Intervention: High-frequency power toothbrush (Philips Sonicare Elite; SE)
Number of subjects: 35
Study 12362747 — intervention group
Group type: EXPERIMENTAL
Intervention: External ankle support (semi-rigid orthosis, air-cast, or high top shoes)
Number of subjects: 3954
Study 12362747 — intervention group
Group type: COMPARATOR
Intervention: No external ankle support (control group)
Number of subjects: 3954
Study 10419244 — intervention group
Group type: EXPERIMENTAL
Intervention: Parvovirus B19 infection
Number of subjects: 47
Study 10419244 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoglobulin treatment
Number of subjects: 47
Study 10419244 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose steroids treatment
Number of subjects: 47
Study 7484314 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance Abuse Subtle Screening Inventory (SASSI)
Number of subjects: 495
Study 7484314 — intervention group
Group type: EXPERIMENTAL
Intervention: Michigan Alcoholism Screening Test (MAST)
Number of subjects: 495
Study 7484314 — intervention group
Group type: EXPERIMENTAL
Intervention: Five direct screening questions
Number of subjects: 495
Study 2202231 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 24
Study 2202231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7040496 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 42
Study 7040496 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 42
Study 30223911 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT+brexpiprazole 1-3 mg/day
Number of subjects: 0
Study 30223911 — intervention group
Group type: COMPARATOR
Intervention: ADT+placebo
Number of subjects: 0
Study 27837671 — intervention group
Group type: EXPERIMENTAL
Intervention: d-cycloserine (125mg)
Number of subjects: 39
Study 27837671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 26458986 — intervention group
Group type: EXPERIMENTAL
Intervention: Movi-Kids intervention (three hour-long sessions of recreational non-competitive physical activity after school, weekly; educational materials for parents and teachers; playground modifications)
Number of subjects: 21
Study 26458986 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 21
Study 24081433 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 130/0.42
Number of subjects: 798
Study 24081433 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 798
Study 24081433 — intervention group
Group type: EXPERIMENTAL
Intervention: Any bleeding
Number of subjects: 798
Study 24081433 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe bleeding
Number of subjects: 798
Study 21819824 — intervention group
Group type: EXPERIMENTAL
Intervention: Closer monitoring by Westat staff
Number of subjects: 2168
Study 21819824 — intervention group
Group type: COMPARATOR
Intervention: Standard monitoring by the Motor Vehicle Administration (Control)
Number of subjects: 2168
Study 18584189 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A 1 unit
Number of subjects: 70
Study 18584189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 17223425 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral LV lead placement
Number of subjects: 61
Study 17223425 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral LV lead placement
Number of subjects: 61
Study 17223425 — intervention group
Group type: COMPARATOR
Intervention: Anterior LV lead placement
Number of subjects: 61
Study 15467498 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (0.15 microg kg(‐1))
Number of subjects: 60
Study 15467498 — intervention group
Group type: COMPARATOR
Intervention: Tramadol (100 mg)
Number of subjects: 60
Study 11583878 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization
Number of subjects: 182
Study 11583878 — intervention group
Group type: COMPARATOR
Intervention: Constant medical therapy
Number of subjects: 182
Study 9337003 — intervention group
Group type: EXPERIMENTAL
Intervention: pyrimethamine and berberine
Number of subjects: 215
Study 9337003 — intervention group
Group type: EXPERIMENTAL
Intervention: pyrimethamine and tetracycline
Number of subjects: 215
Study 9337003 — intervention group
Group type: EXPERIMENTAL
Intervention: pyrimethamine and cotrimoxazole
Number of subjects: 215
Study 7534847 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive therapy with pantripin and contrykal
Number of subjects: 587
Study 7534847 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 587
Study 3309812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin infusion for one hour
Number of subjects: 53
Study 3309812 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin per os in one time
Number of subjects: 53
Study 3309812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin per os during 3 days
Number of subjects: 53
Study 3309812 — intervention group
Group type: COMPARATOR
Intervention: Control group (lens accumulation)
Number of subjects: 53
Study 31754703 — intervention group
Group type: EXPERIMENTAL
Intervention: Darunavir/ritonavir (800/100 mg) + raltegravir (400 mg)
Number of subjects: 805
Study 31754703 — intervention group
Group type: COMPARATOR
Intervention: Darunavir/ritonavir (800/100 mg) + tenofovir disoproxil fumarate/emtricitabine (245/200 mg once daily)
Number of subjects: 805
Study 30421079 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic enucleation (EN Group)
Number of subjects: 25